Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

Structural Basis and Distal Effects of Gag Substrate Coevolution in Drug Resistance to HIV-1 Protease

By Enthusiast Inc MDFebruary 27, 2015

…the structural basis for the co-evolution of I50V/A71V protease with the p1-p6 substrate. Methods: By applying crystallography method and molecular dynamics simulation, we investigate the structural basis of I50V/A71V protease…

DIVERGENT ADAPTIVE IMMUNE RESPONSES DEFINE 2 TYPES OF LONG COVID

By Jimmy He PharmD, DScApril 4, 2022

…binding to spike-expressing 293T cells. For CD4+ T cell response analyses, cytokine production was measured by intracellular staining on primary T cell lines stimulated by immunodominant peptides derived from the…

ON-DEMAND HIV POSTEXPOSURE PROPHYLAXIS BY TAF/EVG VAGINAL INSERTS IN MACAQUES

By Jimmy He PharmD, DScApril 28, 2020

Topical products for HIV prevention that can be administered on-demand, either pre- or post-viral exposure, remain an advantageous regimen for end-users that have infrequent or clustered intercourse or are unable…

5’ UTR SNP RS111686073 MODIFIES EXPRESSION OF TAPASIN IN BLACKS

By Enthusiast Inc MDMarch 5, 2018

Tapasin (hereafter TAPBP) is a transmembrane glycoprotein mediating the binding of TAP and MHC-I within the peptide loading complex in the endoplasmic reticulum, the interaction of which is important for…

HIV TREATMENT/RETENTION IN SUB-SAHARAN AFRICA BEFORE AND DURING THE COVID-19 PANDEMIC

By Jimmy He PharmD, DScApril 22, 2021

…Monitoring, Evaluation, and Reporting (MER) data to assess potential loss to follow-up (LTFU) across PEPFAR countries in SSA before and during the pandemic to determine the impact of COVID-19 on…

575 – HIV Reactivation Potential Evaluated by RNA-Seq and DNA Methylation Following LRA Stimulation

By Jimmy He PharmD, DScMarch 20, 2025

…Nanopore. DNA methylation was analyzed for both 5-methylcytosine (5mC) and N6-methyladenosine (6mA). An algorithm was developed to identify genes and genomic sites potentially associated with HIV inducibility. Transcriptome and epigenome…

Modification of Antibody 10E8 to Improve HIV-1 Neutralization

By Enthusiast Inc MDSeptember 29, 2014

…a membrane context and potentiate its neutralization of HIV-1. Methodology: Antibody residue positions in the vicinity or co-planar with the gp41 contact interface, though not within it, were chosen for…

Pathogenesis of JC Virus Reactivation During Natalizumab Treatment

By Enthusiast Inc MDSeptember 29, 2014

…and determine JCV-specific cellular response during prolonged exposure to the drug. Methodology: We enrolled 39 JCV-seropositive MS patients, including 32 on natalizumab monotherapy for 18-20 months (n=14), 22-25 months (n=7)…

Hepcidin Modifies Effects of Age and Erythrocyte Indices on Cognitive Function in People With HIV

By Jimmy He PharmD, DScMarch 6, 2024

Background: Cognitive impairment (CI) in people with HIV (PWH) is associated with abnormal erythrocyte indices, which may result from inflammation, disturbed iron metabolism, and other factors. Mean corpuscular volume (MCV)…

NOVEL BISPECIFIC ENGAGER REDIRECTS CMV-SPECIFIC CTL TO ELIMINATE HIV-INFECTED CELLS

By Jimmy He PharmD, DScMarch 3, 2023

…to redirect CMV-specific CTLs to eliminate HIV-1 Env-expressing cells and suppress HIV-1 infection. Methods: Donor PBMC treated with NLV-VRC01 RediTac to expand NLV-specific memory CTLs were cocultured with either an…

←1
2345678910111213141516171819202122232425262728293031323334
…3536373839…
40414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top